newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Announces Date of Reconvened Annual Meeting of Shareholders

MALVERN, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the "Company"), a pharmaceutical company focused on innovative products for acute care settings, today announced that it has adjourned its 2022 Annual Meeting of Shareholder